secwatch.observer — SEC 8-K summary
======================================

Issuer:     RetinalGenix Technologies Inc. (RTGN)
CIK:        0001836295
Form:       8-K
Filed at:   2025-02-20T23:59:59+00:00
Accession:  0001493152-25-007703
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RetinalGenix amends warrant to bar exercise until 2030 or 3 yrs after uplisting
-------------------------------------------------------------------------------

- Amendment restricts exercise of 28,014,540-share pre-funded warrant held by Sanovas Ophthalmology, LLC.
- New exercise limitation: earlier of Feb 1, 2030 or 3rd anniversary of uplisting to Nasdaq or NYSE American.
- CEO Jerry Katzman signed for both company and holder (Sanovas Ophthalmology, LLC).
- No other terms of the warrant were modified; $100 consideration paid.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1836295/000149315225007703/0001493152-25-007703-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1836295/000149315225007703/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-007703

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer